rs6750157
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_032977.4(CASP10):c.922+243C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0138 in 963,430 control chromosomes in the GnomAD database, including 1,337 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.062 ( 946 hom., cov: 31)
Exomes 𝑓: 0.0048 ( 391 hom. )
Consequence
CASP10
NM_032977.4 intron
NM_032977.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.79
Publications
1 publications found
Genes affected
CASP10 (HGNC:1500): (caspase 10) This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 3 and 7, and the protein itself is processed by caspase 8. Mutations in this gene are associated with type IIA autoimmune lymphoproliferative syndrome, non-Hodgkin lymphoma and gastric cancer. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CASP10 Gene-Disease associations (from GenCC):
- autoimmune lymphoproliferative syndrome type 2AInheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autoimmune lymphoproliferative syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 2-201208426-C-T is Benign according to our data. Variant chr2-201208426-C-T is described in ClinVar as Benign. ClinVar VariationId is 1243974.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CASP10 | NM_032977.4 | c.922+243C>T | intron_variant | Intron 8 of 9 | ENST00000286186.11 | NP_116759.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0615 AC: 9344AN: 151946Hom.: 944 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
9344
AN:
151946
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00480 AC: 3891AN: 811366Hom.: 391 Cov.: 14 AF XY: 0.00442 AC XY: 1658AN XY: 375420 show subpopulations
GnomAD4 exome
AF:
AC:
3891
AN:
811366
Hom.:
Cov.:
14
AF XY:
AC XY:
1658
AN XY:
375420
show subpopulations
African (AFR)
AF:
AC:
3378
AN:
15410
American (AMR)
AF:
AC:
20
AN:
956
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
5014
East Asian (EAS)
AF:
AC:
1
AN:
3498
South Asian (SAS)
AF:
AC:
6
AN:
15994
European-Finnish (FIN)
AF:
AC:
0
AN:
270
Middle Eastern (MID)
AF:
AC:
12
AN:
1560
European-Non Finnish (NFE)
AF:
AC:
182
AN:
742018
Other (OTH)
AF:
AC:
292
AN:
26646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
147
294
442
589
736
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0616 AC: 9368AN: 152064Hom.: 946 Cov.: 31 AF XY: 0.0596 AC XY: 4429AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
9368
AN:
152064
Hom.:
Cov.:
31
AF XY:
AC XY:
4429
AN XY:
74358
show subpopulations
African (AFR)
AF:
AC:
8850
AN:
41428
American (AMR)
AF:
AC:
358
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
7
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10578
Middle Eastern (MID)
AF:
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
AC:
54
AN:
67996
Other (OTH)
AF:
AC:
97
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
374
748
1121
1495
1869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
39
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Feb 21, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.